Shenzhen - Delayed Quote CNY
Beijing Bohui Innovation Biotechnology Group Co., Ltd. (300318.SZ)
5.79
+0.05
+(0.87%)
At close: April 30 at 3:04:25 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
791,300.35
851,694.58
1,045,429.10
795,932.50
714,748.46
Cost of Revenue
425,671.68
433,610.08
590,566.56
541,137.61
421,917.14
Gross Profit
365,628.67
418,084.50
454,862.54
254,794.89
292,831.32
Operating Expense
339,041.41
346,009.57
385,431.40
345,303.66
390,481.22
Operating Income
26,587.26
72,074.94
69,431.14
-90,508.77
-97,649.90
Net Non Operating Interest Income Expense
-29,865.82
-27,863.63
-24,119.14
-42,221.68
-989.12
Pretax Income
-26,929.25
19,912.60
33,728.13
-133,781.84
-504,180.41
Tax Provision
6,470.68
11,232.73
18,046.66
4,390.10
1,609.50
Net Income Common Stockholders
-14,672.04
9,245.98
-24,929.39
-78,441.33
-322,176.63
Basic EPS
-0.02
--
-0.03
-0.10
-0.39
Diluted EPS
-0.02
--
-0.03
-0.10
-0.39
Basic Average Shares
816,592.21
--
817,357.09
817,097.18
816,877.86
Diluted Average Shares
816,592.21
--
817,357.09
817,097.18
816,877.86
Total Operating Income as Reported
-12,107.94
35,181.52
33,813.82
-127,632.04
-502,305.91
Total Expenses
764,713.09
779,619.64
975,997.96
886,441.27
812,398.36
Net Income from Continuing & Discontinued Operation
-14,672.04
9,245.98
-24,929.39
-78,441.33
-322,176.63
Normalized Income
-10,175.38
15,017.11
-16,475.72
-83,424.09
-49,703.71
Interest Income
690.51
775.42
3,278.61
512.37
350.66
Interest Expense
28,459.65
27,773.47
26,344.89
41,775.44
519.09
Net Interest Income
-29,865.82
-27,863.63
-24,119.14
-42,221.68
-989.12
EBIT
1,530.40
47,686.07
60,073.03
-92,006.40
-503,661.32
EBITDA
1,530.40
151,368.49
172,991.83
17,359.12
-396,002.82
Reconciled Cost of Revenue
425,671.68
433,610.08
590,566.56
541,137.61
421,917.14
Reconciled Depreciation
--
103,682.42
112,918.81
109,365.52
107,658.50
Net Income from Continuing Operation Net Minority Interest
-14,672.04
9,245.98
-24,929.39
-78,441.33
-322,176.63
Total Unusual Items Excluding Goodwill
-7,494.44
-7,694.85
-11,271.56
6,643.69
-363,297.22
Total Unusual Items
-7,494.44
-7,694.85
-11,271.56
6,643.69
-363,297.22
Normalized EBITDA
9,024.84
159,063.34
184,263.39
10,715.44
-32,705.59
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-2,997.77
-1,923.71
-2,817.89
1,660.92
-90,824.31
12/31/2021 - 5/23/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade